BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27226593)

  • 1. Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.
    Orlando BJ; Malkowski MG
    J Biol Chem; 2016 Jul; 291(29):15069-81. PubMed ID: 27226593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2.
    Duggan KC; Hermanson DJ; Musee J; Prusakiewicz JJ; Scheib JL; Carter BD; Banerjee S; Oates JA; Marnett LJ
    Nat Chem Biol; 2011 Nov; 7(11):803-9. PubMed ID: 22053353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib.
    Windsor MA; Valk PL; Xu S; Banerjee S; Marnett LJ
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5860-4. PubMed ID: 24060487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.
    Dong L; Vecchio AJ; Sharma NP; Jurban BJ; Malkowski MG; Smith WL
    J Biol Chem; 2011 May; 286(21):19035-46. PubMed ID: 21467029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex.
    Dong L; Anderson AJ; Malkowski MG
    Biochemistry; 2019 Sep; 58(38):3990-4002. PubMed ID: 31469551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural basis of endocannabinoid oxygenation by cyclooxygenase-2.
    Vecchio AJ; Malkowski MG
    J Biol Chem; 2011 Jun; 286(23):20736-45. PubMed ID: 21489986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid.
    Prusakiewicz JJ; Duggan KC; Rouzer CA; Marnett LJ
    Biochemistry; 2009 Aug; 48(31):7353-5. PubMed ID: 19603831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of rofecoxib bound to human cyclooxygenase-2.
    Orlando BJ; Malkowski MG
    Acta Crystallogr F Struct Biol Commun; 2016 Oct; 72(Pt 10):772-776. PubMed ID: 27710942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.
    Blobaum AL; Xu S; Rowlinson SW; Duggan KC; Banerjee S; Kudalkar SN; Birmingham WR; Ghebreselasie K; Marnett LJ
    J Biol Chem; 2015 May; 290(20):12793-803. PubMed ID: 25825493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin H synthase-2-catalyzed oxygenation of 2-arachidonoylglycerol is more sensitive to peroxide tone than oxygenation of arachidonic acid.
    Musee J; Marnett LJ
    J Biol Chem; 2012 Oct; 287(44):37383-94. PubMed ID: 22942274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
    Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
    Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of NS-398 bound to cyclooxygenase-2.
    Vecchio AJ; Malkowski MG
    J Struct Biol; 2011 Nov; 176(2):254-8. PubMed ID: 21843643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of fenamates as Slo2.1 channel activators.
    Garg P; Sanguinetti MC
    Mol Pharmacol; 2012 Nov; 82(5):795-802. PubMed ID: 22851714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of fatty acid substrate binding to cyclooxygenase-2.
    Vecchio AJ; Simmons DM; Malkowski MG
    J Biol Chem; 2010 Jul; 285(29):22152-63. PubMed ID: 20463020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
    Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
    Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating substrate promiscuity in cyclooxygenase-2: the role of Arg-120 and residues lining the hydrophobic groove.
    Vecchio AJ; Orlando BJ; Nandagiri R; Malkowski MG
    J Biol Chem; 2012 Jul; 287(29):24619-30. PubMed ID: 22637474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase competitive inhibitors alter tyrosyl radical dynamics in prostaglandin H synthase-2.
    Wu G; Tsai AL; Kulmacz RJ
    Biochemistry; 2009 Dec; 48(50):11902-11. PubMed ID: 19894761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
    Dong L; Sharma NP; Jurban BJ; Smith WL
    J Biol Chem; 2013 Oct; 288(40):28641-55. PubMed ID: 23955344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-Methylarachidonic acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase.
    Kudalkar SN; Nikas SP; Kingsley PJ; Xu S; Galligan JJ; Rouzer CA; Banerjee S; Ji L; Eno MR; Makriyannis A; Marnett LJ
    J Biol Chem; 2015 Mar; 290(12):7897-909. PubMed ID: 25648895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385.
    Rowlinson SW; Kiefer JR; Prusakiewicz JJ; Pawlitz JL; Kozak KR; Kalgutkar AS; Stallings WC; Kurumbail RG; Marnett LJ
    J Biol Chem; 2003 Nov; 278(46):45763-9. PubMed ID: 12925531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.